TERT and glioblastoma: Aquilanti et al. reported the application of CRISPRi (clustered regularly interspaced palindromic repeats interface) for the transcriptional silencing of TERT exon 1 and the TERT promoter in GBM cell lines (98G, LN18, and SF295) and patient-derived models [5].